The top 10 most expensive drugs of 2013. Future goes orphan!

Among the 20 most expensive drugs, only hep C fighter Sovaldi, Roche's breast cancer drug Kadcyla and Bristol-Myers Squibb's ($BMY) colon cancer drug Erbitux are not orphans, drugs approved under a special program to motivate companies to develop treatments for conditions that usually have patient populations of fewer than 200,000.
http://www.fiercepharma.com/special-reports/top-10-most-expensive-drugs-2013